Latest immunotherapies Stories
Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer PLYMOUTH MEETING, Pa., Jan.
Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.
Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.
ORLANDO, Fla., Jan. 5, 2015 /PRNewswire/ -- Immune Therapeutics Inc.
SAN DIEGO, Dec. 15, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SCIB1 continues to generate highly encouraging survival data; Modi-1 vaccine on track for 2016 entry into clinic NOTTINGHAM, England, December 10, 2014 /PRNewswire/ --
Invetech to supply automated production systems for commercialization of patient-specific immunotherapies based on Argos' proprietary Arcelis® technology platform. SAN DIEGO and DURHAM,
PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.
New Executive Brings Experience from Merck, Boehringer Ingelheim, and Proctor & Gamble PLYMOUTH MEETING, Pa., Sept. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.